(19)

(11)

EP 4 798 213 A1

(12)

(43) Date of publication: 02.09.2026 Bulletin 2026/36 (21) Application number: 24883020.0 (22) Date of filing: 24.01.2024

(51) International Patent Classification (IPC):  A61K 31/7076(2006.01) C07H 19/167(2006.01) A61P 27/06(2006.01) A61K 9/00(2006.01) A61P 27/02(2006.01) (52) Cooperative Patent Classification (CPC): A61P 27/02; A61K 31/7076; A61P 27/06; A61K 9/0048; A61K 9/0051; A61K 45/06; A61K 31/52   C-Sets: A61K 31/52, A61K 2300/00; (86) International application number: PCT/US2024/012760 (87) International publication number: WO 2025/090106 (01.05.2025 Gazette 2025/18)

(84) Designated Contracting States: AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR Designated Extension States: BA Designated Validation States: GE KH MA MD TN (30) Priority: 23.10.2023 US 202363592471 P 21.12.2023 US 202363613610 P (71) Applicant: Ophthalmic Therapeutic Innovation, Inc. Watertown, Massachusetts 02472 (US)	(72) Inventor: QIU, Guanting Peabody, Massachusetts 01960-8024 (US) (74) Representative: Maschio & Soames IP Ltd  30 Carlton Crescent Southampton SO15 2EW Southampton SO15 2EW (GB)